Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2000 3
2001 3
2002 3
2003 6
2004 4
2005 5
2006 3
2007 3
2008 4
2009 5
2010 4
2011 10
2012 4
2013 9
2014 8
2015 9
2016 7
2017 7
2018 8
2019 5
2020 11
2021 17
2022 13
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Results by year

Filters applied: . Clear all
Page 1
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial.
Pieber TR, Bode B, Mertens A, Cho YM, Christiansen E, Hertz CL, Wallenstein SOR, Buse JB; PIONEER 7 investigators. Pieber TR, et al. Lancet Diabetes Endocrinol. 2019 Jul;7(7):528-539. doi: 10.1016/S2213-8587(19)30194-9. Epub 2019 Jun 9. Lancet Diabetes Endocrinol. 2019. PMID: 31189520 Clinical Trial.
Guest editorial.
Adali T, Yavuz DO. Adali T, et al. Among authors: yavuz do. Int J Biol Macromol. 2019 Apr 15;127:701. doi: 10.1016/j.ijbiomac.2019.01.160. Epub 2019 Jan 29. Int J Biol Macromol. 2019. PMID: 30708023 No abstract available.
Biochemical characteristics and calcium and PTH levels of patients with high normal and elevated serum 25(OH)D levels in Turkey: DeVIT-TOX survey.
Pekkolay Z, Yavuz DG, Saygılı ES, Değertekin CK, Topaloğlu Ö, Önder ÇE, Soylu H, Taskaldıran I, Pazır AE, Uğur K, Tanrıkulu S, Fırat SN, Atak BM, Batman A, Omma T, Cağıltay E, Özdemir N, Altuntaş SÇ, İmga NN, Karakılıç E, Hekimsoy Z, Kılınç F, Yay A, Eroğlu M, Tuzcu AK. Pekkolay Z, et al. Among authors: yavuz dg. Arch Osteoporos. 2021 Sep 18;16(1):138. doi: 10.1007/s11657-021-01002-8. Arch Osteoporos. 2021. PMID: 34536116
Drug hypersensitivity in drug-resistant tuberculosis.
Katran ZY, Bulut İ, Babalık A, Keren M, Tepetam FM, Mersin SS, Örçen C, Yakut T, Yavuz D. Katran ZY, et al. Among authors: yavuz d. World Allergy Organ J. 2023 May 20;16(5):100778. doi: 10.1016/j.waojou.2023.100778. eCollection 2023 May. World Allergy Organ J. 2023. PMID: 37251814 Free PMC article.
148 results